Acta Diabetologica, 2024
Clinical, genomic, and proteomic perspectives in the analysis of comorbid conditions in type 2 diabetes mellitus: a retrospective study

Villikudathil A., Mc Guigan D., English A.

Molecular Therapy - Methods & Clinical Development, 2024
Comparative assessment of the transduction efficiency and safety associated with the delivery of AAV9-GFP vector via lumbar puncture to cynomolgus macaques with and without anti-AAV9 pre-existing antibodies

Guibinga G., Do J., Chu B. et al.

ESC Heart Failure, 2024
Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

Zhu X., Liu G., Peng Y. et al.

Journal of Experimental & Clinical Cancer Research, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors

Jirovec E., Quixabeira D., Clubb J. et al.

BMC Medicine, 2024
BMI trajectories from birth to young adulthood associate with distinct cardiometabolic profiles

Wang G., Wei D., Kebede Merid S. et al.

Circulation: Heart Failure, 2024
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy

Tahir U., Kolm P., Kwong R. et al.

Journal of Crohn's and Colitis, 2024
Characterisation of IBD heterogeneity using serum proteomics: A multicentre study

Salomon B., Sudhakar P., Bergemalm D. et al.

Journal of Inflammation Research, 2024
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels

Chen Y., Wang Z., Liang Y. et al.

MedComm, 2024
An inflammatory cytokine signature predicts IgA nephropathy severity and progression

Chen L., Chen X., Cai G. et al.

European Heart Journal Open, 2024
Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug (NSAID) users

Vaja R., Ferreira P., Portas L. et al.

Genes & Immunity, 2024
The HLA-B –21 M/T dimorphism associates with disease severity in COVID-19

Strunz B., Momayyezi P., Bilev E. et al.

Cell Metabolism, 2024
Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems

Goeminne L., Vladimirova A., Eames A. et al.

ImmunoTargets and Therapy, 2024
Causality Between 91 Circulating Inflammatory Proteins and Various Asthma Phenotypes: A Mendelian Randomization Study

Zhang S., Zhang X., Wei C. et al.

The American Journal of Clinical Nutrition, 2024
Human milk feeding practices and serum immune profiles of 1-y-old infants in the CHILD birth cohort study

Ames S., Lotoski L., Rodriguez L. et al.

Clinical Journal of the American Society of Nephrology, 2024
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins

Kobayashi H., Looker H., Ihara K. et al.

Molecular Neurodegeneration, 2024
Proteomic analysis of APOEε4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience

Walker K., An Y., Moghekar A. et al.

Journal of Translational Medicine, 2024
Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features

Yang M., Yu H., Feng H. et al.

Frontiers in Psychiatry, 2024
Mendelian randomization analysis of causal and druggable circulating inflammatory proteins in schizophrenia

Cao H., Fu L., Liu D. et al.

GeroScience, 2024
Plasma proteomics-based organ-specific aging for all-cause mortality and cause-specific mortality: a prospective cohort study

Zhao R., Lu H., Yuan H. et al.

Scientific Reports, 2024
Plasma metabolites as mediators in the relationship between inflammation-related proteins and benign prostatic hyperplasia: insights from mendelian randomization

Cui Y., Wang H., Wang Y.